SCYNEXIS, Inc. - Common Stock (NQ:SCYX)

3.670 -0.240 (-6.14%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SCYNEXIS, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Scynexis, Inc. (SCYX)

September 29, 2023

From Kirby McInerney LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors

September 29, 2023

From Law Offices of Howard G. Smith

Via Business Wire

SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating SCYNEXIS, Inc. on Behalf of Scynexis Stockholders and Encourages Investors to Contact the Firm

September 28, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

SCYNEXIS: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Looking Into SCYNEXIS's Return On Capital Employed ↗

April 03, 2023

Via Benzinga

Scynexis Inc. (NASDAQ: SCYX) Leading the Way in Thursday Trading Based on Percentage Gain

March 30, 2023

Via Investor Brand Network

GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks ↗

March 30, 2023

Via Benzinga

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors

September 28, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors

September 27, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors

September 25, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors

September 25, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Gold Moves Lower; TransCode Therapeutics Shares Surge ↗

September 25, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to...

Via Benzinga

Topics Stocks

The Law Offices of Frank R. Cruz Announces Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors

September 25, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 25, 2023

Via Benzinga

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 25, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Via Benzinga

Nasdaq Turns Higher; SCYNEXIS Shares Plunge ↗

September 25, 2023

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500...

Via Benzinga

Topics Stocks

Why Are Antifungal Focused Scynexis Stock Plunging Today? ↗

September 25, 2023

Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga

Via Benzinga

U.S. Stocks Open Lower; Chicago Fed Index Falls In August ↗

September 25, 2023

U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 25, 2023

Via Benzinga

Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now ↗

August 28, 2023

While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator.

Via InvestorPlace

Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗

August 16, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 15, 2023

Via Benzinga

WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens

May 19, 2023

Cranford, New Jersey--(Newsfile Corp. - May 19, 2023) - WBB Research Institute (WBBRI) hosted...

Via Newsfile

Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher ↗

March 30, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 30, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections

March 30, 2023

SCYNEXIS, Inc. (NASDAQ: SCYX) operates as a biotechnology company, which is focused on the research and development of novel solutions

Via Spotlight Growth

Warner Music Layoffs: What to Know About the Latest WMG Job Cuts ↗

March 30, 2023

Warner Music (WMG) layoffs have the entertainment company cutting 4% of its workforce, or 270 jobs, during economic uncertainty.

Via InvestorPlace

Why Is EVgo (EVGO) Stock Up 25% Today? ↗

March 30, 2023

EVgo (EVGO) stock is on the rise Thursday following the release of its earnings report for the fourth quarter of the year!

Via InvestorPlace

Why Is Scynexis (SCYX) Stock Up 69% Today? ↗

March 30, 2023

Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.